Rogério Antonio de Oliveira (Rogerio Oliveira, Rogério A Oliveira)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Prostate Cancer

Cell Proliferation

Bioinformatics Analysis

Radiation Therapy

Top Venues

Molecular genetics and genomics : MGG

Revista da Associacao Medica Brasileira (1992)

Universidade Estadual Paulista Júlio de Mesquita Filho

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidade Estadual Paulista Júlio de Mesquita Filho Sep 05 2011

Brazil

Professor Assistente Doutor :: Depto Bioestatística - IBB

Synchrophar Assessoria e Desenvolvimento de Projetos Clínicos S/S, SYNCHROPHAR, Brasil. Oct 01 2008 - Jul 30 2011

Brazil

Estatístico habilitado pela Agência Nacional de Vigilância Sanitária (ANVISA) :: Etapa Estatística - Clinical Trials Analysis

Publications

Adauto Lima Cardoso, Natália Bortholazzi Venturelli, Irene da Cruz, Fábio Malta de Sá Patroni, Diogo de Moraes, Rogério Antonio de Oliveira, Ricardo Benavente, Cesar Martins
Meiotic behavior, transmission and active genes of B chromosomes in the cichlid Astatotilapia latifasciata: new clues about nature, evolution and maintenance of accessory elements. Molecular genetics and genomics : MGG 297 (4) (2022)
Gustavo Arruda Viani, Caio Viani Arruda, Rogério Antonio de Oliveira
Cost-effectiveness analysis comparing intensity-modulated radiotherapy with conformational radiotherapy (3D-RT) for prostate cancer in the brazilian health system. Revista da Associacao Medica Brasileira (1992) 67 (5) (2021)
Cristiano P Souza, Naiara C Cinegaglia, Tainara F Felix, Adriane Feijó Evangelista, Rogério Antonio de Oliveira, Erica N Hasimoto, Daniele Cristina Cataneo, Antonio José Maria Cataneo, Cristovam Scapulatempo Neto, Cristiano R Viana, Flávia E de Paula, Sandra Aparecida Drigo Linde, Robson Francisco Carvalho, Márcia M C Marques, Rui Manuel Vieira Reis, Patrícia Pintor Reis
Deregulated microRNAs Are Associated with Patient Survival and Predicted to Target Genes That Modulate Lung Cancer Signaling Pathways. Cancers 12 (9) (2020)